These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32111888)

  • 1. Genetic and pharmacological inhibition of inflammasomes reduces the survival of Mycobacterium tuberculosis strains in macrophages.
    Subbarao S; Sanchez-Garrido J; Krishnan N; Shenoy AR; Robertson BD
    Sci Rep; 2020 Feb; 10(1):3709. PubMed ID: 32111888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
    Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA
    Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection.
    Guo Y; Li L; Xu T; Guo X; Wang C; Li Y; Yang Y; Yang D; Sun B; Zhao X; Shao G; Qi X
    J Clin Invest; 2020 Dec; 130(12):6301-6316. PubMed ID: 33104527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.
    Primiano MJ; Lefker BA; Bowman MR; Bree AG; Hubeau C; Bonin PD; Mangan M; Dower K; Monks BG; Cushing L; Wang S; Guzova J; Jiao A; Lin LL; Latz E; Hepworth D; Hall JP
    J Immunol; 2016 Sep; 197(6):2421-33. PubMed ID: 27521339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B
    Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
    J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity.
    Gao Y; Xu G; Ma L; Shi W; Wang Z; Zhan X; Qin N; He T; Guo Y; Niu M; Wang J; Bai Z; Xiao X
    Cell Commun Signal; 2021 Feb; 19(1):13. PubMed ID: 33573688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis.
    Trachalaki A; Tsitoura E; Mastrodimou S; Invernizzi R; Vasarmidi E; Bibaki E; Tzanakis N; Molyneaux PL; Maher TM; Antoniou K
    Front Immunol; 2021; 12():661811. PubMed ID: 34220810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis.
    Sendler M; van den Brandt C; Glaubitz J; Wilden A; Golchert J; Weiss FU; Homuth G; De Freitas Chama LL; Mishra N; Mahajan UM; Bossaller L; Völker U; Bröker BM; Mayerle J; Lerch MM
    Gastroenterology; 2020 Jan; 158(1):253-269.e14. PubMed ID: 31593700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome activation in murine macrophages caused by Neospora caninum infection.
    Wang X; Gong P; Zhang X; Wang J; Tai L; Wang X; Wei Z; Yang Y; Yang Z; Li J; Zhang X
    Parasit Vectors; 2017 May; 10(1):266. PubMed ID: 28558839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation.
    Han C; Godfrey V; Liu Z; Han Y; Liu L; Peng H; Weichselbaum RR; Zaki H; Fu YX
    Sci Immunol; 2021 May; 6(59):. PubMed ID: 33963060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice.
    Xu KY; Tong S; Wu CY; Ding XC; Chen JL; Ming Y; Wang SH
    Transplantation; 2020 Jun; 104(6):e151-e163. PubMed ID: 32108749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
    Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis Utilizes Serine/Threonine Kinase PknF to Evade NLRP3 Inflammasome-driven Caspase-1 and RIPK3/Caspase-8 Activation in Murine Dendritic Cells.
    Rastogi S; Ganesh A; Briken V
    J Immunol; 2024 Sep; 213(5):690-699. PubMed ID: 39018500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18.
    Zhong WJ; Duan JX; Liu T; Yang HH; Guan XX; Zhang CY; Yang JT; Xiong JB; Zhou Y; Guan CX; Li Q
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107045. PubMed ID: 33045564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.